Serial Number | 76122109 |
Word Mark | CREATIVITY INTELLIGENTLY APPLIED |
Filing Date | Wednesday, August 23, 2000 |
Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
Status Date | Tuesday, July 15, 2003 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 1000 - Typeset: Word(s) / letter(s) / number(s) |
Published for Opposition Date | Tuesday, October 22, 2002 |
Goods and Services | Medical diagnostic and therapeutic preparations and devices for administering same, sold filled, with diagnostic and therapeutic preparations, all for administration via diverse routes of administration including through the respiratory airways, and, medical devices for administering the pharmaceuticals, sold filled, the preparations including nucleotides, proteins and organic molecules for medical use, including macromolecules such as anti-sense oligonucleotides and enzymes and small organic and inorganic molecules for treatment of human and non-human animal respiratory, central nervous system, neoplastic, endocrine, immune and cardiovascular ailments, including bronchoconstriction, difficult breathing, impeded and obstructed lung airways, allergy(ies) andior inflammation, which in some cases are adenosine receptor associated symptoms; pharmaceutical preparations for testing, and preventing and therapeutically treating respiratory, airway and pulmonary diseases and conditions, such as asthma, pulmonary vascoconstriction, inflammation, allergies, impeded respiration, Acute Respiratory Disease Syndrom (ARDS), renal damage and failure, ischemia resulting from the administration of certain drugs, including adenosine and other drugs for, for example, treating SupraVentricular Tachycardia (SVT), adenosine stress tests, infantile Respiratory Distress Syndrome (infantile RDS), pain, cystic fibrosis, allergic rhinitis, allergic bronchitis, pulmonary hypertension, pulmonary vascoconstriction, emphysema, chronic obstructive pulmonary disease (COPD), as well as cancers including leukemias, lymphomas, carcinomas, and the like, eg colon cancer, breast cancer, lung cancer, pancreatic cancer, hepatocellular carcinoma, kidney cancer, melanoma, etc, as well as all metastatic cancers, eg, cancers which metastasized to the lung(s), breast, liver and prostate |
Pseudo Mark | CREATIVITY INTELLIGENTLY APPLIED |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, September 21, 2000 |
Primary Code | 005 |
First Use Anywhere Date | Friday, May 31, 1996 |
First Use In Commerce Date | Friday, May 31, 1996 |
Party Name | EPIGENESIS Pharmaceuticals, Inc. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | Cranbury, NJ 08512 |
Party Name | EPIGENESIS Pharmaceuticals, Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Cranbury, NJ 08512 |
Event Date | Event Description |
Thursday, September 25, 2003 | ABANDONMENT - NO USE STATEMENT FILED |
Tuesday, January 14, 2003 | NOA MAILED - SOU REQUIRED FROM APPLICANT |
Tuesday, October 22, 2002 | PUBLISHED FOR OPPOSITION |
Wednesday, October 2, 2002 | NOTICE OF PUBLICATION |
Wednesday, July 17, 2002 | Sec. 1(B) CLAIM ADDED |
Wednesday, July 17, 2002 | SEC. 1(A) CLAIM DELETED |
Monday, July 15, 2002 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Friday, July 5, 2002 | ASSIGNED TO EXAMINER |
Wednesday, June 19, 2002 | EXAMINERS AMENDMENT MAILED |
Tuesday, March 5, 2002 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Wednesday, January 16, 2002 | FINAL REFUSAL MAILED |
Thursday, September 27, 2001 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Thursday, March 22, 2001 | NON-FINAL ACTION MAILED |
Thursday, March 8, 2001 | ASSIGNED TO EXAMINER |
Tuesday, February 13, 2001 | ASSIGNED TO EXAMINER |